News
The use of 5-aminosalicylic acid with ustekinumab shows no significant overall benefits in inflammatory bowel disease. However, post hoc subgroup analyses suggest potential benefits in specific ...
5-ASA: 5-aminosalicylic acid; 6-MP: 6-mercaptopurine; AZA: Azathioprine. Data taken from [55,56]. 5-ASA: 5-aminosalicylic acid; NS: Nonsignificant; pts: Patients; q.i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback